市場調査レポート

癌幹細胞市場の動向

Cancer Stem Cell Trends

発行 Global Industry Analysts, Inc. 商品コード 297793
出版日 ページ情報 英文 23 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
癌幹細胞市場の動向 Cancer Stem Cell Trends
出版日: 2014年01月01日 ページ情報: 英文 23 Pages
概要

当レポートでは、米国および欧州における成長市場である癌幹細胞(CSC)市場について調査分析を行い、市場概要を考察するとともに、癌などの病気の増加や規制機関による償還の支援などといった市場促進因子、主要企業などについてまとめ、概略下記の構成で取り上げております。

第1章 癌幹細胞のレポート

  • イントロダクション
  • CSCの前提
  • 概要
  • 薬理学的研究と現代の分子生理学
  • 制限と矛盾
  • 定義の難しいCSCの起源
  • CSCインビトロモデル
  • CSCの性質
  • CSCの同定と特性化
  • CSCの排除‐腫瘍の再発防止のカギ

第2章 技術の概要

  • 加速する癌幹細胞研究
  • CSCの存在:議論の的
  • CSC研究に関する誇大宣伝
  • 数理モデル
  • 細胞経路
  • CSCとWnt経路
  • 焦点接着キナーゼ(FAK)
  • CSC研究の将来

第3章 市場の情報

  • 癌幹細胞と循環腫瘍細胞市場

第4章 主な市場参加者

  • Boston Biomedical, Inc.(米国)
  • Macrogenics(米国)
  • Verastem, Inc.(米国)

第5章 企業/研究の取り組み

第6章 付録

目次
Product Code: 141066

The report illustrates on the growing market for Cancer Stem Cells (CSCs) in the US and Europe The major factors stimulating the growth of the market are the rising affliction of diseases such as cancer and the reimbursement assistance by regulatory organizations in developed nations including the US and Europe. Cancer Stem Cells (CSCs) are the cells within a tumor that possess the capability of self-renewal and driving tumorigenesis. In the previous research studies, rare CSCSs have been isolated from several human tumors such as brain, breast, colon and haematopoietic cancers. CSCs are believed to survive in tumors as a completely distinct population and might cause metastasis and relapse by producing new tumors. In addition, the report highlights the exponential rise in research on Cancer Stem Cells (CSCs), and the design of novel drugs to treat CSCs. Major players in the field include Boston Biomedical Inc., Macrogenics, and Verastem, Inc.

Table of Contents

1. CANCER STEM CELLS - A FOCUS REPORT

  • Prelude
  • CSC Hypothesis
  • An Overview
  • Impact on Pharmacology Research and Modern Molecular Physiology
  • Limitations and Inconsistencies
  • Origin of CSCs Remains Elusive
  • CSC In Vitro Models
    • Cells from Tumor Lines
    • Genetic Manipulation of Cell Lines
    • Sorted Tumor Cells Selection
  • Properties of CSCs
  • Identification and Characterization of CSCs
  • Elimination of CSCs - The Key in Preventing Tumor Reappearance

2. TECHNOLOGY OVERVIEW

  • Research on Cancer Stem Cell Accelerates
  • Existence of CSCs - A Topic of Debate
  • Hype Surrounding CSC Research Fails to Fetch End Results
  • Mathematical Models
  • Cellular Pathways
  • CSCs and the Wnt Pathway
  • Focal Adhesion Kinase (FAK)
  • Future of CSC Research

3. MARKET INFORMATION

  • Cancer Stem Cells and Circulating Tumor Cells Market

4. NOTEWORTHY MARKET PARTICIPANTS

  • Boston Biomedical, Inc. (USA)
  • Macrogenics (USA)
  • Verastem, Inc. (USA)

5. CORPORATE/RESEARCH INITIATIVES

  • Bionomics Acquires Eclipse Therapeutics
  • Dainippon Sumitomo Pharma Acquires Boston Biomedical
  • Queensland University Scientists to Study Ovarian CSCs
  • Sanford-Burnham Researchers Study Isolated Ovarian CSCs
  • Harvard Medical School Researchers Suspect Radiotherapy and Chemotherapy in Development of CSCs
  • Mount Sinai School of Medicine Leads Research on CSCs to Develop New Therapies
  • University of Texas Scientists Research to Arrest Cancer Re-growth
  • McMaster's Stem Cell and Cancer Research Institute Scientists Discover Thioridazine's Potential to Kill CSCs
  • Ohio State University College of Medicine Proposes Cancer Stem Cells (CSCs) Theory
  • Research Collaboration Identifies Potential of Gamma-Tocotrienol
  • Research on Maintenance Mechanism by Cancers
  • Verastem to Develop Drugs Targeting Cancer Stem Cells
  • University of Michigan Researchers Study the Role of Cancer Stem Cells in Ovarian Cancer
  • Hong Kong Researchers Find CSCs with CD24 Surface Protein Aggravate Liver Cancer
  • CRUK to Research on Cancer-Combating Drugs
  • University of Michigan Researchers Use Experimental Drugs to Inhibit Breast Cancer
  • University of Pittsburgh Researchers Discover Prevention of Isolated CSCs from Differentiating

6. APPENDIX

Back to Top